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We recently cloned from a mouse 3T3 cell eDNA library a eDNA with sequence similarity to the p42 "~ protein and other members 
of the MAP kinase family. To determine with certainty which member of the family this clone encodes, we have expressed the eDNA in COS ceils 
and characterized the protein product. When the pSV2MAP plasmid carrying the full-length clone was transfected into COS cells, a protein of 42 000 
Da was expressed. This 42 kDa protein displayed chromatographic properties indistinguishable from the endogenous p42 ""r~, and could be 
separated from the closely related pp44. In addition, upon serum stimulation, the 42 kDa protein became tyrosine-phosphorylated nd enzymatically 
active towards the substrate myelin basic protein. We conclude that this clone codes for a functional p42 re"p* protein kinase. 
Protein kinase; Phosphotyrosine; MAP kinase; COS cell, Transient expression 
1. INTRODUCTION 
Ray and Sturgill originally identified the pp42/MAP 
kinase protein (p42 "~pk) as a serine/threonine protein 
kinase [I-3] which required phosphorylation on both 
threonine and tyrosine residues to be enzymatically ac- 
tive [4]. The two sites of  regulatory phosphorylation 
were found to reside on a single tryptic peptide, separat- 
ed by only one amino acid [5]. 
An apparently similar enzyme was purified and se- 
quenced by Cobb and co-workers, a partial eDNA 
clone based on this sequence was obtained from a rat 
brain library [6] and this clone was named ERKI .  Since 
the amino acid sequence surrounding the regulatory 
phosphorylation sites o f  p42 '''pk was 85% identical to 
the equivalent region in ERK1 [5], we used oligonu- 
cleotides based on the ERKI  sequence to screen a 3T3 
eDNA library, with the expectation that a p42 ""pk clone 
could be obtained [7]. With the ERK1 oligonucleotides 
we were able to isolate a number of ERK I  clones as well 
as a full-length eDNA corresponding to a candidate 
p42 ""pk clone. The deduced amino acid sequence of this 
clone predicted a 42 kDa protein exhibiting the charac- 
teristic features of  a serine/threonine protein kinase and 
containing a sequence identical to the site of regulatory 
phosphorylation we had previously determined for 
p42 '""pk [5,7]. 
Although we suspected that this clone encoded the 
p42 "~pk protein, this issue was complicated by the fact 
that p42 "~k is a member of  a protein kinase family 
which includes at least four mammalian members [8] 
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and several related proteins in amphibians [9] and inver- 
tebrates [10]. The site o f  regulatory phosphorylation is 
highly conserved even in the yeast k~ra~.ses FUS3 [I 1] 
and KSSI [12]. Different family members function 
variously in intracellular signaling during the G0---->G~ 
transition [13,14] or during mitosis [9] or upon activa- 
tion of terminally differentiated cells [15]. Since the 
p42 ""pk protein we purified was from EL4 thymoma 
cells [5] it was by no means certain that the 3T3 eDNA 
clone we obtained encoded the authentic p42 "'opk de- 
scribed by Sturgill and collaborators [3], or whether 
some other family member, with different regulatory or 
biochemical properties, might have been obtained. 
To examine the relationship between te p42 ''~pk pro- 
tein and the eDNA isolated with ERK1 probes, we 
constructed a transient expression vector (pSV2MAP) 
carrying the full-length eDNA clone and transfected it 
into mammalian COS cells. This transient expression 
system has been successfully used to characterize nu- 
merous DNA sequences. We show here that a 42 kDa 
protein was over-expressed and demonstrate that this 
protein possessed the biochemial, regulatory and en- 
zymatic features expected for the p42 "'~p~ protein. 
2. MATERIALS  AND METHODS 
2.1. Materials 
Fetal calf serum, bovine calf serum and lipofectin reagent were 
purchased from Gibco BRL, Life Technologies, Inc., Gaithersburg, 
MD. The phenyl-Superose column and pheayl-Sepharose were from 
Pharrnaeia.LKB. [~5I]protein A, donkey anti.rabbit horseradish per- 
oxidase (HRP) antibody and ECL (Electro Chemi-Luminescence) kit 
were all purchased from Amersham, Arlington, IL. [?'-3~P]ATP (6000 
Ci/mmol) was from NEN-DuPon~ Research Products, Wilmington, 
DE. Specifi, anti-phosphotyrosine a tisera were generated in this 
laboratory as described [13]. The anti-MAP kinase antiserum was 
generated against a peptide corresponding to the C-terminal amino 
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acids of the ERK1 sequence, ARFQPGPEAP [6] using the MAPS 
procedure Jig]. The corresponding predicted sequence in our p42 "~v~ 
clone is ARFQPGYRS [7]. The IgG fraction of the antiserum was 
obtained by protein G chromatography. 
The pBluescript plasmid was purchased from Stratagene, La Jolla, 
CA. All other molecular biology reagents were the highest quality 
commercially available. 
2.2 Construction of a vector for transient expression of recombinant 
p42 ~vk cDNA 
The full length p42 "~ eDNA was first cloned from a Agtl0 eDNA 
library into pBlueseript [7]. For transient expression of p42 "~'~ in 
COS-7 cells, the 1.3 kb H~ndlII/SmaI fragment containing the p42 "~r~ 
gene was further subcloned i~to pSV2CAT with the ehloramphenicol 
acetyl transferase (CAT) gene being cut out using/-/indIIl and Hpal 
restriction enzymes. In thsi vector, the p42 ""p~ eDNA is driven by the 
SV40 early promoter and transcription is terminated by the SV40 
polyadenylation signal downstream from the HpaI/SmaI site. 
2.3. Cell c'ulture and transfection experiments 
The cell line COS-7 (ATCC) was grown at 37°C in a 7.5% CO., 
incubator, with Dulbceco's modified Eagle medium (DMEM) supple- 
mented with 5% calf serum ÷ 5% fetal calf serum until 80-90% con- 
fluence. The plates were then washed twice with serum-free DMEM 
before adding fresh serum-free DMEM containing the lipo- 
fectin-DNA complex [17]. Complex formation was achieved by dilut- 
ivg 10-15/,tg DNA and 30/zg lipofectin into 4 ml DMEM. After 6 h 
incubation, the solution was aspirated and 10% fetal calf serum- 
supplemented DMEM was added. The cells were harvested after 36- 
72 h of expression. 
2.4. Cell lysis, FPLC purication and en:ymatic activity 
These procedures were performed as previously described [14.18]. 
2.5. Western immunoblotting 
Anti-p42 "''# blots were incubated ar 37°C in phosphate-buffer 
saline (PBS) supplemented with 5% low-fat dried milk (PBS-milk). 
They were first pre-blocked 0.5 h before probing with anti-p42 ""~ 
antiserum (for 2 h). Blots were then washed 3 times in PBS-milk and 
reacted for I h with secondary antibody conjugated to horse radish 
peroxidas¢. Blots were washed 3 times again before applying the ECL 
kit for I rain at room temperature. Immediately after, X-ray films were 
exposed for I0 to I rain, Anti-phosphotyrosine rnmunoblots were 
revealed as described elsewhere [14]. 
3. RESULTS 
3.1. Transient expression levels of p42 m"~k h~ whole cell 
lysates 
The vector pSV2MAP was first constructed (see Ma- 
terials and Methods) from the transient e~pression vec- 
tor pSV:CAT in which the CAT gene was replaced by 
the full-length cDNA coding for a member of the MAP 
kinase family, presumably p42 ''~?~. Then, the pSV:MAP 
plasmid was transfected in the presence of the lipofectin 
reagent [17] into COS-7 cells far tr~,n~ient expression. 
Fig. 1 shows anti-MAP kinase immunoblots of the 
time-course of induction of p42 '''°pk expression in this 
mammalian cell line. The only immunoreactive band 
which was newly expressed after the transfection of the 
pSV:MAP plasmid had an Mr of 42 000. This expres- 
sion was detected from 1.5-3 days after transfection, 
with a peak at 2.5 days. However, when the empty 
vector pSV~CAT was introduced, no difference, corn- 
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Fig. l.Time-course of p42 ' '~ protein expression in COS ceils. Cells 
were transfected as described in Methods and were lysed at the indica- 
ted times (in days). An anti-MAP kinase immunoblot of whole cell 
lysates (50/.tg protein per lane) is presented and is typical of three 
independent experiments, pSV2CAT is the empty vector, pSV,MAP 
is the vector expressing p42 ""~. 
pared to the basal evels, was detectable in the intensity 
of the p42 band 1.5 days after transfection (see Fig. 1) 
or 2.5 days (data not shown). 
Fibroblastie cells which have been examined express 
at least two members of the MAP kinase family, p42 '''~" 
and another protein of 44 kDa [19-21], which we refer 
to as p44 ''"pA [19]. We have previously noticed that where- 
as p42 ''''~k can readily be detected with anti-phospho- 
tyrosine antibodies in a Western blot ofelectrophoresed 
total cell lysates, the p44 ''''pk could not be consistently 
detected [13,14,18] unless the proteins were first separat- 
ed on 2-D-gels [18]. We speculated that a protein of 
around 44 kDa (such as actin) could inhibit the interac- 
tion of p44 "''pk with the antibodies. To determine wheth- 
er a similar explanation could account for our failure to 
detect he 44 kDa protein in the immunoblots shown in 
Fig. 1, we took advantage of the fact that p42 '''"rk and 
p44 '"pk are capable of binding to hydrophobic chroma- 
tography matrices, such as phenyl-Sepharose. When 
phenyl-Sepharose was utilized to partially purify the 
MAP kinases, and the eluted proteins were separated by 
gel electrophoresis, both p42 ''"pk and the 44 kDa protein 
could be detected with the anti-MAP kinase antiserum 
(Fig. 2, left panel). Note that when COS cells were 
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Fig. 2. Expression and tyrosine phosphorylation of partially purified MAP kinases, Cells from 100 mm dishes were lysed by Dounce homogenization 
in hypotonic buffer and subjected to batch-wise partial purification of MAP kinases on DEAE cellulose and then phenyl-Sepharose, essentially 
as described [2,3,5] except hat the phenyI-Sepharose was washed with 20% ethylene glycol, prior to elution with 60% ethylene glycol. The partially 
purified preparations were electrophoresed (25% of eluted material per lane), transferred to nitrocellulose and probed either with the anti-MAP 
kinase antibody or with anti.phosphotyrosine antibody. Vectors: O, untransfected cells; E, empty vector, pSV,CAT; M, pSV,MAP. Serum: -, 
incubated in serum-free DMEM for 2 h; +, cultured in the continuous presence of serum; ++, serum-starved for 2 h then stimulated for 10 rain 
with 10% fetal calf serum. 
transfected with the pSV2MAP plasmid, only the lower 
band increased in amount, demonstrating that the clone 
encodes p42 m"p~, not p44 "opk. In addition, the 42 kDa 
region contained a doublet of proteins reactive with the 
anti-MAP kinase antiserum. It si possible that the upper 
band in the doublet is the phosphorylated form of 
p42 "'"p*, and the lower form is unphosphorylated.: since 
we have observed a similar small mobility shift in 
p42 '''pk following serum stimulation of 3T3 cells (Ros- 
somando and Weber, unpublished). Both the p42 ''"pk 
and the 44 kDa protein could be detected with antibod- 
ies against phosplaotyrosine (right panel, Fig. 2). When 
cells were cultured in the continuous presence of serum 
(+), both proteins displayed a level of tyrosine phosphor- 
ylation which was only marginally higher than was seen 
in serum-starved cells (-). Serum stimulation of quieg- 
cent cells resulted in substantially increased tyrosine 
phosphorylation of both pp42 and pp44 (++). Inter- 
estingly, in all these cases the extent of phosphorylation 
was higher on the p42 ""pk protein than on the 44 kDa 
protein. We do not know whether this reflects diffe- 
rences in the ability of serum to induce phosphorylation 
of these proteins, or whether the pho~phorylated 44
kDa protein simple binds less well to phenyl-Sepharose. 
3.2. Expression, phosphorylation and activation of puri- 
fied p42 m"pk 
Various membranes of the MAP kinase protein fa- 
mily can be separated by FPLC column chromatogra- 
phy, particularly using the, hydrophobic interaction 
resin phenyl-Superose, and a double-gradient of in- 
creasing ethylene glycol and decreasing NaCI [2,3,19]. 
The p42 ''"~k binds exceptionally tightly to this resin, and 
elutes at approximately 37% ethylene glycol and 100 
mM NaCI, whereas p44 ''"pk binds much less tightly and 
elutes with many other cellular proteins and kinases 
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Fig. 3. Chromatography of p42 " '~ on phenyl.Superose. After 2.5 days ofe~pression, cells transfectcd with empty vector (pSV2CAT) or MAP kinase 
vector (pSV:MAP) were serum-deprived for 18 h before lysis. Cell lysates were fraetionated by DEAE and phenyl-Superose chromatography as
described [2,14,18], fractions were subjected to 10% SDS-PAGE. followed by immunoblotting with anti-MAP kinase antibody. Fraction numbers 
are indicated at the bottom of the figure. 
193 
Volume 292, number 1,2 FEBS LETTERS November 1991 
• . .  • . • . . . . .  . ' . . . . . .  ! -~ ,~. ;  : , . . ,  ~ : 
• . . . . . . . . .  :..: .:::~..?: .. 
pSV2CA T . . . .  . , . .  . .  • . . :~.~.  • • .  
, .  . " . . . .  . . "  . .  . .  • - . . . .  
' ' " YI. . "~:  ~"  '~  
• . .  . .  
' . . . . , .  . . . . . .  . ~  
• . . :  . ,  • . . .  • . . 




. . . . . . . . . . . . . . . . . . . . . . .  . . . . . . . . . .  :,..: ........ ....--~ :../.,....:.~:,.:-:~.~m,~..:~.,~,~.~-.~..,:,:,~,.:~,:::,~.~}'.~*-",;--- 
=; . . - : ,~ : ' . .~ : "  . " . - " : ' . .  . . ? . . :~ ' "  " :" " :"  "~ ~':~..'.':~ :~ . . -~  "~ i " " i "  " .~  "¢  " 
~i::~i./?. . . 'i " " .- ~. ".~ :) ~.,~...'.: :'~/..'/T:II!"..:' • i ~..": .. -: . .. 
: '~( ' " . .~  . : ' "  : : ~" .  " ~ . .  . '  i "~ ' "  . .  . -  . . . .  : . "  " " " " , . . .  
e; :~:  ". i :~" :  . .  • " . . ' . . . .  " - • . - -~v . . - ' .  " " " : "~~O""  " " " 
:~ ' . "  " '~ .~ . . . . .  . • . :  • " "1 , "  . • " • " " . .  . • -:~ .~ ' .  " " 
~i . . . . . . , .~ . . . . . ,~ . . .~ : .  : . .  . . . .~ : .  . 
~" : . ' "  Y . : ?  . " .  : : " " " " i " ~ • • " V .  • 
m 
. . .  • 
'.. ," :".. . :i.i. . :" . . - - - , -~ I~B . . " ~ , ,~4 • ." " ~ 
. .  " . . . . .  . • 
• . • , .  , " : "  "1 )  . • . .  . • .~ .  
• . . ,  . • . - . ' . .  " .  . .  
: :  " • ._~... ... , , .  :. .).':~JJ'~q;L: • " 
10 . . . . . .  24 26 . , .  10 , , ,  , , ,24  26 ,  , ,  
4pp42 
Fig. 4. Phosphotyrosine content o f  purified p42 ~p* protein. Cells were transfected with pSV:CAT (two top panels) or pSVzMAP (two bottom 
panels). After 2.5 days of  expression cells were serum-deprived for 18 h and reactivated (two right panels, +) or  not (two left panels, - )  with I0% 
fetal calf serum for 10 rain. Anti -phosphotyrosine immunoblots  from phenyl-Superose purified material (!.5 mg protein per FPLC run) are 
presented. Fraction numbers  are indicated at the bottom of  the figure. 
during the wash or early in the gradient [14,19]. When 
lysates of cells transfected with pSV2MAP were subject- 
ed to purification on phenyl-Superose, increased ex- 
pression of p42 '~pk could be detected by immunoblot- 
ring with anti-MAP kinase antibodies, compared to ly- 
sates of cells transfected with the empty vector 
pSV2CAT (Fig. 3). The over-expressed p42 ''~p~ eluted 
from phenyl-Superose at the characteristic elution posi- 
tion of the MAP kinase described by Ray and Sturgill 
[2,3,19]. 
Parallel blots of phenyl-Superose-purified p42 ''~pk 
probed with anti-phosphotyrosine a tibodies are shown 
in Fig. 4. They indicate that the level of tyrosine phos- 
phorylation present on the endogenous p42 "~pk protein 
(from cells transfected with the empty pSV2CAT vector) 
is increased following serum stimulation of the cells. 
This is the expected result, since tyrosine phosphoryla- 
tion of p42 ~ork has been demonstrated in various cell 
systems in response to serum, growth factors and other 
agonists. In cells transfected with pSV2MAP vector, the 
phosphorylation f p42 "ark purified from quiescent cells 
was increased, compared to cells transfected with empty 
vector, and was further enhanced by serum stimulation. 
These findings demonstrate that the over-expressed 
p42 ''apk also displays enhanced tyrosine phosphoryla- 
tion in response to serum treatment. 
Fig. 5 displays the kinase activity of the fractions 
shown in Fig. 4 which contained the p42"~P*': because 
other unrelated kinases are present in the early fractions 
from this column, these were not suitable for assay of 
p44. The results clearly show that there is an excellent 
correlation between the levels of tyrosine-phosphorylat- 
ed p42 ''~Èk and the levels of a2p-incorporation to the 
substrate myelin basic protein, a characteristic feature 
of phenyl-Superose-purified p42 ''opk [3,13,14,18,19,22]. 
4. DISCUSSION 
The functional expression in mammalian cells of a 
full-length eDNA encoding a member of the recently 
characterized MAP kinase family is described for the 
first time in this paper. The over-expressed p42 '''ap~ pro- 
tein can be visualized on whole cell blots (Fig. 1) as well 
as Western blots from material partially purified on 
phenyl-Sepharose (Fig. 2), and more highly purified on 
phenyl-Superose (Fig. 3), thus excluding the possibility 
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Fig. 5. Purified I>42 "~ activity in transfccted COS cells. Pbenyl-Supcr- 
ose fractions from the experiment shown in Fig. 4 (5/J] out of ] ml 
for each) were analyzed for their capacity to phosphorylate myelin 
basic protein [22]. Fraction umbers are indicated at the bottom of the 
figure. COS cells transfected ither with pSV2CAT (c~,A) or pSVzMAP 
(<>,~,) were serum-deprived for 18 h and reactivated (A,*) or not (z~,<,) 
with 10% FCS for 10 rain. Results are typical of two kinase assays. 
that the enhanced expression is an artefact of the purifi- 
cation procedures. However, the levels of expression 
appeared to be higher when whole cell lysates were 
blotted than when purified material was assessed. The 
reasons for this discrepancy are not understood. How- 
ever, it is conceivable that a portion of the over-ex- 
pressed protein does not achieve the appropriate con- 
formation and thus does not behave normally during 
column chromatography. 
We conclude from this study that the clone we iso- 
lated previously [7] encodes a completely functional 
p42 ''~pk protein: the over-expressed protein encoded by 
our clone migrates at the molecular weight of 42 kDa 
in SDS-polyacrylamide g l electrophoresis, elutes at 
37% ethylene glycol from a phenyl-Superose column, is 
tyrosine-phosphorylated in response to growth factors, 
and is enzymatically active towards the relatively specif- 
ic substrate myelin basic protein. Finally, the presence 
of the two signals, tyrosine phosphorylation and en- 
zymatic activity, correlate xtremely well after purifica- 
tion (see Figs. 4 and 5). All these features are charac- 
teristic of the p42 ""vk protein described in several cell 
systems [3,13-15,18,19,22]. 
These results establish that the ERKl-related clone 
we isolated [7] is full-length and that it codes for the 
original p42 '''~pk protein described by Sturgill and co- 
workers. This clone, which corresponds to the ERK2 of 
Boulton et al. [8] can now be reliably used to elucidate 
the mechanism of activation of p42 "~rk and its functions 
in cell regulation. Transient expression in the COS cell 
system should be particularly suitable for these studies 
if over-expression f p42 '"~p* inhibits cell growth or has 
long-term effects on cellular regulation. Such conse- 
quences of over-expression would make it difficult to 
isolate stable over-expresser cell lines or to unambigu- 
ously interpret the results of over-expression. Although 
COS cells are transformed, we show here that the over- 
expressed p42 "~@ undergoes normal agonist-induced 
phosphorylation a d enzymatic activation i  these cells. 
Thus, the COS cell system can be used not only for the 
identification of members of the MAP kinase family, 
but also for studies on the regulation of their activity. 
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